- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03868761
Feasibility and Efficacy of a Digital Mental Health Intervention for Teen Wildfire Survivors
November 23, 2020 updated by: Adrienne Julie Heinz, Stanford University
Feasibility and Preliminary Efficacy of a Digital Mental Health Intervention to Reduce Symptoms of Post-Disaster Traumatic Stress, Depression, and Anxiety in Teens Impacted by Wildfires: A Randomized Multiple-Baseline Single-Case Study.
In October, 2017, Northern California experienced devastating and historic wildfires.
Sonoma Rises is an app designed for anyone who was impacted by this event and is intended to help survivors of disaster find their new normal.
This study will assess the feasibility and efficacy of a self-help post-disaster mental health intervention delivered via a mobile app with a sample of teens who are experiencing post-disaster mental health symptoms.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
7
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Stanford University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 17 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males & females aged 13-17 years directly impacted by the 2017 wildfires having lost their home or been temporarily displaced
- Screen positive for PTSD (Child Trauma Screening Questionnaire = 5 or higher)
- Have regular access to a smart phone and a computer
- Have a personal email address
- Speak and read English fluently
- Have parental consent
Exclusion Criteria:
- A positive self-reported history of psychosis, bipolar, or schizophrenia
- Serious self-reported physical health concerns necessitating surgery or with prognosis <6 months
- A positive screen for a current Substance User Disorder (CRAFFT = 2 or higher)
- Current self-reported suicidal ideation
- Self-reported pregnancy
- Self-reported less than four weeks of stable prescription medication for anxiety, anti-depressant, and sleep promoting medications prior to the screening assessment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Single Arm
21 male and female teenage participants will be randomized to one of three varying baseline assessment periods of two, four, or six weeks.
Multiple baseline is a type of single-case experimental design (SCED) that is a time- and cost-effective method for evaluating efficacy of a new treatment, Sonoma Rises.
The randomization of participants to baseline periods of varying lengths enables assessment of whether symptom changes occur when, and only when, the intervention is applied.
|
All participants will receive the intervention, Sonoma Rises, a mobile app designed by psychologists at the National Center for PTSD for wildfire survivors to facilitate recovery from disaster.
Users can access evidence-informed tools to help cope with stress, heal from loss, prioritize self-care, connect with others, manage anger, and track their mood using validated assessments.
There are also tools designed just for teens and users are linked to psychoeducation on disaster and health and other mental health resources and services.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: intervention retention: number of treatment completers
Time Frame: 4 months
|
retention (i.e., number of treatment completers)
|
4 months
|
|
Feasibility: intervention safety: number of adverse events
Time Frame: 4 months
|
safety (i.e., number of adverse events)
|
4 months
|
|
Feasibility: intervention adherence: number of treatment components completed
Time Frame: 4 months
|
adherence rates (i.e., number of treatment components completed)
|
4 months
|
|
Feasibility: intervention satisfaction/acceptability
Time Frame: 4 months
|
satisfaction/acceptability (i.e., participant satisfaction with treatment "how would you rate your overall satisfaction with the program?"- range 0-10 - higher score indicates more satisfaction)
|
4 months
|
|
Feasibility: intervention promotion
Time Frame: 4 months
|
Net promoter score (i.e., "How likely are you to recommend this to a friend?"
score range 0-5; lower score indicates higher likelihood of promotion)
|
4 months
|
|
Feasibility: engagement rate
Time Frame: 4 months
|
Engagement rate (i.e., Number and average length of logins to the mobile app intervention)
|
4 months
|
|
PTSD Symptom Severity
Time Frame: 4 months
|
Child PTSD Symptom Scale for Diagnostic and Statistical Manual-5; score ranges from 0-80; higher scores indicate more PTSD symptom severity
|
4 months
|
|
PTSD functional impairment
Time Frame: 4 months
|
Child PTSD Symptom Scale for Diagnostic and Statistical Manual-5; score ranges from 0-7; higher scores indicate more PTSD related functional impairment
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Internalizing symptoms
Time Frame: 4 months
|
Behavior and Feelings Survey - Youth; range 0-24; higher scores indicate more internalizing symptoms (anxiety, depression, stress)
|
4 months
|
|
Externalizing symptoms
Time Frame: 4 months
|
Behavior and Feelings Survey- Youth; range 0-24; higher scores indicate more externalizing symptoms (behavior problems)
|
4 months
|
|
Psychosocial functioning
Time Frame: 4 months
|
Ohio Youth Scale - Functioning Subscale; Score range 0-80; higher score indicated better functioning
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Adrienne Heinz, Ph.D., Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2019
Primary Completion (Actual)
January 31, 2020
Study Completion (Actual)
November 22, 2020
Study Registration Dates
First Submitted
March 5, 2019
First Submitted That Met QC Criteria
March 8, 2019
First Posted (Actual)
March 11, 2019
Study Record Updates
Last Update Posted (Actual)
November 24, 2020
Last Update Submitted That Met QC Criteria
November 23, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-49196
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
VA Office of Research and DevelopmentCompleted
-
Oregon Health and Science UniversityNational Center for Advancing Translational Sciences (NCATS); Oregon Clinical...Terminated
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
-
University of Wisconsin, MadisonCompleted
-
Wake Forest University Health SciencesWithdrawn
Clinical Trials on Sonoma Rises
-
Thomas Jefferson UniversityTim ReynoldsSuspendedSpinal Cord Diseases | Spinal Cord InjuriesUnited States
-
Thomas Jefferson UniversityKessler FoundationActive, not recruitingSpinal Cord Diseases | Spinal Cord InjuriesUnited States